Search Results - "Kalyan, Narender K"

Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice by Johnson, J. Erik, McNeil, Lisa K, Megati, Shakuntala, Witko, Susan E, Roopchand, Vidia S, Obregon, Jennifer H, Illenberger, Deanne M, Kotash, Cheryl S, Nowak, Rebecca M, Braunstein, Emily, Yurgelonis, Irene, Jansen, Kathrin U, Kalyan, Narender K, Sidhu, Maninder K

“…Highlights ► rVSV-RSV replicon vectors elicit potent neutralizing antibodies in vivo. ► rVSV-RSV vectors elicit primary and memory Th1-biased cellular…”
Get full text

In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation by Erik Johnson, J, Coleman, John W, Kalyan, Narender K, Calderon, Priscilla, Wright, Kevin J, Obregon, Jennifer, Ogin-Wilson, Eleanor, Natuk, Robert J, Clarke, David K, Udem, Stephen A, Cooper, David, Michael Hendry, R

“…Abstract Recombinant vesicular stomatitis viruses (rVSVs) are being developed as potential HIV-1 vaccine candidates. To characterize the in vivo replication…”
Get full text

Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression by Witko, Susan E., Johnson, J. Erik, Kalyan, Narender K., Felber, Barbara K., Pavlakis, George N., Sidhu, Maninder K., Hendry, R. Michael, Udem, Stephen A., Parks, Christopher L.

“…Propagation-defective vesicular stomatitis virus (VSV) vectors that encode a truncated G protein (VSV-Gstem) or lack the G gene entirely (VSV-ΔG) are…”
Get full text

Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1 by Kalyan, N K, Lee, S G, Wilhelm, J, Pisano, M R, Hum, W T, Hsiao, C L, Davis, A R, Eichberg, J W, Robert-Guroff, M, Hung, P P

“…Haemagglutinin (HA), the major surface glycoprotein of influenza virus, is a potent immunogen against which viral neutralizing antibodies are directed. Studies…”
Get more information

Alterations in the Domain Structure of Tissue-Type Plasminogen Activator Change the Nature of Asparagine-Linked Glycosylation by Wilhelm, James, Lee, Shaw Guang, Kalyan, Narender K, Cheng, Sheau Mei, Wiener, Frank, Pierzchala, Walter, Hung, Paul P

Get full text

Deglycosylation increases the fibrinolytic activity of a deletion mutant of tissue-type plasminogen activator by Wilhelm, J, Kalyan, N K, Lee, S G, Hum, W T, Rappaport, R, Hung, P P

“…delta 2-89 t-PA is a deletion mutant lacking the finger (F) and epidermal growth factor (EGF) domains; thus, the fibrin interaction of this molecule must be…”
Get more information

Effect of deglycosylation on the subunit interactions and receptor binding activity of human chorionic gonadotropin by Kalyan, N K, Bahl, O P

Get more information

Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life by Weinheimer, C J, James, H L, Kalyan, N K, Wilhelm, J, Lee, S G, Hung, P P, Sobel, B E, Bergmann, S R

“…Despite the utility of tissue-type plasminogen activator (t-PA) in eliciting coronary thrombolysis clinically, early reocclusion remains a problem, occurring…”
Get full text

Expression and secretion of human atrial natriuretic alpha-factor in Bacillus subtilis using the subtilisin signal peptide by Wang, L F, Wong, S L, Lee, S G, Kalyan, N K, Hung, P P, Hilliker, S, Doi, R H

“…Using the signal peptide of the Bacillus subtilis subtilisin gene (aprE) and a synthetic cDNA corresponding to the mature region of the human atrial…”
Get more information

Effect of modification of galactose residues on the biological properties of asialo human choriogonadotropin by Madnick, H M, Kalyan, N K, Segal, H L, Bahl, O P

Get more information